27 related articles for article (PubMed ID: 15106362)
1. Premenopausal serum androgens and breast cancer risk: a nested case-control study.
Zeleniuch-Jacquotte A; Afanasyeva Y; Kaaks R; Rinaldi S; Scarmo S; Liu M; Arslan AA; Toniolo P; Shore RE; Koenig KL
Breast Cancer Res; 2012 Feb; 14(1):R32. PubMed ID: 22339988
[TBL] [Abstract][Full Text] [Related]
2. Report from the HarmoSter study: different LC-MS/MS androstenedione, DHEAS and testosterone methods compare well; however, unifying calibration is a double-edged sword.
Fanelli F; Peitzsch M; Bruce S; Cantù M; Temchenko A; Mezzullo M; Lindner JM; Hawley JM; Ackermans MT; Van den Ouweland J; Koeppl D; Nardi E; MacKenzie F; Binz PA; Rauh M; Keevil BG; Vogeser M; Eisenhofer G; Heijboer AC; Pagotto U
Clin Chem Lab Med; 2024 May; 62(6):1080-1091. PubMed ID: 38205643
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum DHEAS and oxidative stress levels of body mass index in healthy postmenopausal women.
Goy B; Atmaca M; Aslan M; Ucler R; Alay M; Seven I; Demir H; Ozturk M
Redox Rep; 2016 Mar; 21(2):61-6. PubMed ID: 26024430
[TBL] [Abstract][Full Text] [Related]
4. Prediction of tumor size in patients with invasive ductal carcinoma using FT-IR spectroscopy combined with chemometrics: a preliminary study.
Zhu Z; Chen C; Chen C; Yan Z; Chen F; Yang B; Zhang H; Han H; Lv X
Anal Bioanal Chem; 2021 May; 413(12):3209-3222. PubMed ID: 33751160
[TBL] [Abstract][Full Text] [Related]
5. Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer.
El-Hussiny MA; Atwa MA; Rashad WE; Shaheen DA; Elkady NM
Contemp Oncol (Pozn); 2017; 21(1):42-47. PubMed ID: 28435397
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients.
Collina F; Cerrone M; Peluso V; Laurentiis MD; Caputo R; Cecio RD; Liguori G; Botti G; Cantile M; Bonito MD
Am J Transl Res; 2016; 8(8):3530-9. PubMed ID: 27648143
[TBL] [Abstract][Full Text] [Related]
7. Effect of leptin receptor Q223R polymorphism on breast cancer risk.
Mohammadzadeh G; Ghaffari MA; Bafandeh A; Hosseini SM
Iran J Basic Med Sci; 2014 Aug; 17(8):588-94. PubMed ID: 25422752
[TBL] [Abstract][Full Text] [Related]
8. Effect of LEPR Gln223Arg polymorphism on breast cancer risk in different ethnic populations: a meta-analysis.
He BS; Pan YQ; Zhang Y; Xu YQ; Wang SK
Mol Biol Rep; 2012 Mar; 39(3):3117-22. PubMed ID: 21698367
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of leptin, insulin, and lipids in relation to breast cancer in china.
Han C; Zhang HT; Du L; Liu X; Jing J; Zhao X; Yang X; Tian B
Endocrine; 2005 Feb; 26(1):19-24. PubMed ID: 15805581
[TBL] [Abstract][Full Text] [Related]
10. Serum testosterone levels and excessive erythrocytosis during the process of adaptation to high altitudes.
Gonzales GF
Asian J Androl; 2013 May; 15(3):368-74. PubMed ID: 23524530
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer: Targeting of Steroid Hormones in Cancerogenesis and Diagnostics.
Valko-Rokytovská M; Očenáš P; Salayová A; Kostecká Z
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070921
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels.
Asseryanis E; Ruecklinger E; Hellan M; Kubista E; Singer CF
Gynecol Endocrinol; 2004 Jan; 18(1):29-36. PubMed ID: 15106362
[TBL] [Abstract][Full Text] [Related]
13. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
Milewicz T; Krzysiek J; Janczak-Saif A; Sztefko K; Krzyczkowska-Sendrakowska M
Endokrynol Pol; 2005; 56(6):883-90. PubMed ID: 16821206
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum dehydroepiandrosterone sulfate, androstenedione, and sex hormones in men and women.
Phillips GB
Eur J Endocrinol; 1996 Feb; 134(2):201-6. PubMed ID: 8630520
[TBL] [Abstract][Full Text] [Related]
15. Determinants of serum leptin levels in healthy postmenopausal women.
Lambrinoudaki I; Christodoulakos G; Panoulis C; Botsis D; Rizos D; Augoulea A; Creatsas G
J Endocrinol Invest; 2003 Dec; 26(12):1225-30. PubMed ID: 15055477
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
